Discover how NCOA6 loss is associated with aggressive prostate cancer and EGFR overexpression, highlighting potential ...

A comprehensive review published in Genes and Environment examines the complex relationship between tobacco smoking and ...

A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer ...

In this Review, the authors address the clinicopathological features, available treatments and oncological outcomes associated with major rare prostate cancer histological subtypes, and highlight the ...

Adding darolutamide to standard treatment for aggressive prostate cancer reduced the risk of the disease spreading in an ...

Howard Smith’s urologist told him his prostate cancer was not the kind you die with: “It’s the one that’s going to kill you.” ...

Three phase 3 prostate cancer results from ESMO 2026 cover long-term survival with abiraterone in metastatic disease, Erleada before and after surgery, and an update on Truqap for PTEN-deficient ...

Bayer’s Nubeqa is already well established in prostate cancer, but DASL-HiCaP data broadens potential patient populations.

Nov. 4, 2026 Scientists have discovered a compound that transforms a natural muscle-repair protein into a more powerful version dubbed "Super HGF," more than doubling its ability to bind to a key ...

DASL-HiCaP Trial Shows Darolutamide Improves Metastasis-Free Survival in Very High-Risk Prostate Cancer / DASL-HiCaP Trial, ...